Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Vanillylmandelic acid is an active metabolite of (–)-norepinephrine (Item No. 16673).1 It is formed from (–)-norepinephrine via normetanephrine (Item No. 38792) and 4-hydroxy-3-methoxyphenylglycol (Item No. 19714) intermediates by several enzymatic reactions. Vanillylmandelic acid (10 mg/kg) reduces ventricular tachyarrhythmia severity in a rat model of myocardial ischemia injury induced by coronary artery occlusion.2 It has been used as a urinary marker for catecholamine-secreting tumors.1,3
WARNING This product is not for human or veterinary use.
1. Sources and significance of plasma levels of catechols and their metabolites in humans. J. Pharm. Exp. Ther. 305(3), 800-811 (2003).
2. Vanillylmandelic acid protects against reperfusion injury in an experimental animal model of myocardial infarction. Pathophysiology 26(3-4), 343-347 (2019).
3. Competitive enzyme immunoassay for urinary vanillylmandelic acid. Clin. Chim. Acta 264, 177-192 (1997).